Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1.7Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-226.5
Enterprise Value $M4.6EPS (TTM) $-1.3Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-10.6Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-23.6Quick Ratio0.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-4.3Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-549.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M12.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ECTE

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ECTE is held by these investors:



ECTE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHOENBART ALAN WAYNECFO AND SECRETARY 2015-05-20Buy2,500$1.44-94.44view
Hollander Scott WaynePRESIDENT AND CEO 2015-05-20Buy8,000$1.48-94.59view
Nordlicht Mark10% Owner 2014-06-30Buy65,739$2.2-96.36view
Nordlicht Mark10% Owner 2014-06-26Buy17,300$2.2-96.36view
Nordlicht Mark10% Owner 2014-06-24Buy16,961$2.2-96.36view
GOLDBERG MICHAEL M 2014-02-28Sell0$0-96.36view
Nordlicht Mark10% Owner 2013-12-10Buy69,569$2.75-97.09view
Platinum Partners Value Arbitr10% Owner 2013-07-11Sell0$0-97.09view
Doman Robert FDirector 2013-03-22Buy15,000$0.8-90view
GRIECO WILLIAMDirector 2013-03-21Buy30,000$0.76-89.47view

Quarterly/Annual Reports about ECTE:

News about ECTE:

Articles On GuruFocus.com
5 Healthcare Picks for 2012 Mar 21 2012 

More From Other Websites
Echo Therapeutics Announces Dismissal of Federal Court Action Dec 21 2016
Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of... Dec 12 2016
/C O R R E C T I O N -- Manchester Management LLC/ Dec 06 2016
Echo Therapeutics, Inc. Announces Second Quarter 2016 Financial Results Aug 12 2016
Echo Therapeutics Delisted from Nasdaq, Shares Plummet Jul 12 2016
Echo Therapeutics Common Stock to Transition from NASDAQ to OTCQB Jul 08 2016
Platinum Partners to Shut Down Main Fund; Here Are Its 5 Stock Picks Jul 05 2016
Echo Therapeutics Begins Testing of NextGen CGM System Components Jun 29 2016
Echo Therapeutics Gets Fresh Patent For Non-Invasive Sensing Technology Jun 22 2016
Echo Therapeutics Announces New Patent for its Non-Invasive Sensing Technology Jun 22 2016
Echo Therapeutics Announces Institutional Review Board (IRB) Approval of New Protocol Jun 13 2016
Echo Therapeutics Says It's In Final Stage Of Clinical Research Organization Selection Jun 02 2016
Echo Therapeutics in Final Stage of Clinical Research Organization (CRO) Selection Jun 02 2016
Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results May 20 2016
Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA May 17 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation into... May 06 2016
Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes... May 04 2016
Echo Therapeutics Announces Significant Progress in Key Development Milestones May 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)